Plain-English translation of NCT05313620 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ulcerative Colitis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing how , a newer treatment for ulcerative colitis, affects your blood's ability to clot. Researchers want to understand whether this medication changes how your blood clots compared to other standard ulcerative colitis drugs. This information will help doctors understand if there are any blood clotting risks associated with this treatment.
Many people with ulcerative colitis don't respond well to current standard treatments, so doctors are looking for new options like this medication. However, before widely recommending any new treatment, researchers need to understand how it affects the body — in this case, whether it changes blood clotting in ways that could be harmful.
If you join this study, you'll either take the new medication daily or one of the standard ulcerative colitis treatments, depending on which group you're assigned to. The research team will take blood samples at the beginning and during your treatment to measure how your blood clots. Healthy volunteers will also be asked to provide a blood sample for comparison. The study involves both lab tests on blood samples and ongoing monitoring while you receive your assigned treatment.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Spain